日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategies

加快创新抗肿瘤药物进入首次人体试验的速度,并纳入关键的降低风险策略

Yuqi Wang,Quan Quan,Camille Gleason,Helin Yu,Lujia Peng,Yanshen Kang,Ling Jiang,Kailun Wu,Jie Pan,Moxiyele Bao,Qing Zhu,Meiqi Yi,Ming Fang,Yue Zheng,Ling Qiu,Bin Xu,Xiang Li,Jinfeng Song,Jiamu Sun,Zheng Zhang,Zijun Su,Jara Lin,Yuanyuan Xie,April Xu,Xiling Song,Chichi Huang,Zhirong Shen,Lai Wang,Jing Song

Interleukin-35 Regulates Immune Microenvironment of Autoimmune Hepatitis Through Inducing the Expansion of Myeloid-Derived Suppressor Cells.

白细胞介素-35通过诱导髓系来源抑制细胞的扩增来调节自身免疫性肝炎的免疫微环境

Lian Min, Zhang Jun, Zhao Li, Chen Xiang, Peng Yanshen, Wang Qixia, Chen Shengliang, Ma Xiong

Mucosal-Associated Invariant T Cells Improve Nonalcoholic Fatty Liver Disease Through Regulating Macrophage Polarization

黏膜相关不变T细胞通过调节巨噬细胞极化改善非酒精性脂肪肝疾病

Li, Yanmei; Huang, Bingyuan; Jiang, Xiang; Chen, Weihua; Zhang, Jun; Wei, Yiran; Chen, Yong; Lian, Min; Bian, Zhaolian; Miao, Qi; Peng, Yanshen; Fang, Jingyuan; Wang, Qixia; Tang, Ruqi; Gershwin, M Eric; Ma, Xiong

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis

原发性胆汁性胆管炎中Rank-Rankl轴的定量分析

Lleo, Ana; Bian, Zhaolian; Zhang, Haiyan; Miao, Qi; Yang, Fang; Peng, Yanshen; Chen, Xiaoyu; Tang, Ruqi; Wang, Qixia; Qiu, Dekai; Fang, Jingyuan; Sobacchi, Cristina; Villa, Anna; Di Tommaso, Luca; Roncalli, Massimo; Gershwin, M Eric; Ma, Xiong; Invernizzi, Pietro

Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.

通过改变 Cthrc1 基因表达治疗胆汁淤积性纤维化:对自身免疫性和非自身免疫性肝病的影响

Bian Zhaolian, Miao Qi, Zhong Wei, Zhang Haiyan, Wang Qixia, Peng Yanshen, Chen Xiaoyu, Guo Canjie, Shen Li, Yang Fan, Xu Jie, Qiu Dekai, Fang Jingyuan, Friedman Scott, Tang Ruqi, Gershwin M Eric, Ma Xiong